MAWAG
PFE icon

Mid-American Wealth Advisory Group’s Pfizer PFE Stock Holding History

Mid-American Wealth Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-220
Closed -$5.33K – 236
2025
Q2 		$5.33K Buy
+220
New +$5.13K ﹤0.01% 224
2023
Q3 		– Sell
-23,289
Closed -$838K – 64
2023
Q2 		$838K Buy
+23,289
New +$906K 0.65% 40
2022
Q1 		$1.2M Sell
23,244
-1,269
-5% -$65.8K 0.94% 34
2021
Q4 		$1.45M Buy
+24,513
New +$1.21M 1.16% 24

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Mid-American Wealth Advisory Group's PFE Position: Q3 2025 in Review

Mid-American Wealth Advisory Group sold out of Pfizer (PFE) in Q3 2025, closing a stake of 220 shares — an estimated $5.33K sold.

Mid-American Wealth Advisory Group first reported a position in PFE in Q4 2021 and held it in 4 quarters. The position peaked at $1.45M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Mid-American Wealth Advisory Group reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Mid-American Wealth Advisory Group sold 220 Pfizer shares in Q3 2025, an estimated $5.33K.
  • Mid-American Wealth Advisory Group first reported a position in Pfizer in Q4 2021 and held it in 4 quarters.
  • Mid-American Wealth Advisory Group's Pfizer position peaked at $1.45M in Q4 2021.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Mid-American Wealth Advisory Group's 13F filing for Q3 2025, filed 20 Oct 2025.